Recent posts

TypePostAuthorRepliesLast updated
Blog entryHarvoni & Sovaldi, Xtandi in Top 20 Costliest Medicare Drugs Zack Struver01 hour 27 min ago
Blog entryLetter from 56 non-profits and experts to Secretary of State John Kerry on pressure on global access to medicines initiatives Zack Struver05 days 8 min ago
Blog entryHuman Rights Council adopts watershed resolution on Access to Medicines thiru01 week 6 hours ago
Blog entryRoger Bate: Eclectic booster of corporate views thiru01 week 3 days ago
Blog entrySeptember 2004: TACD's Future of WIPO Conference thiru01 week 4 days ago
Blog entryFrancis Gurry appoints Sylvie Forbin, lobbyist for Vivendi, as new head of copyright at WIPO James Love01 week 4 days ago
Page2016: KEI comments on NIH proposal for exclusive licenses to Chimeron Bio Corporation Diane Singhroy01 week 6 days ago
Blog entryGates Foundation v. Teachscape: Restrictions on Patenting of Gates-Funded Inventions Andrew Goldman01 week 6 days ago
PageAndrew S. Goldman, Counsel, Policy and Legal Affairs Claire Cassedy02 weeks 3 days ago
Blog entry2016: KEI/MSF comments to NIH on licensing of patents on Attenuated Respiratory Syncytial Virus (RSV) Vaccines James Love02 weeks 4 days ago
Blog entrySCP 24 - A fruitful discussion? Staff02 weeks 4 days ago
Blog entryWIPO Marrakesh Treaty for the blind to come into force September 30, 2016, following ratification by Canada James Love02 weeks 5 days ago
Book pageKEI Achievements Staff02 weeks 6 days ago
Blog entrySCP24: African Group submits revised proposal for a WIPO work program on Patents and Health thiru03 weeks 1 day ago
Blog entrySCP24: KEI statement on Patents and Health thiru03 weeks 5 days ago
PageBackground FAQ on Glivec (imatinib) compulsory license in Colombia Zack Struver03 weeks 5 days ago
Blog entryApril 28, 2016 letter regarding US Senate Finance threats over compulsory license on Novartis cancer drug patents KEI Staff03 weeks 5 days ago
PageWIPO SCCR 32 - links to KEI's reports from the meeting Manon Ress03 weeks 5 days ago
PageNews reports on Senator Hatch pressure over Colombia compulsory license on Novartis drug James Love03 weeks 5 days ago
Blog entryBriefing Call on National Institutes of Health (NIH) patent policies, 29 June 2016, 11:00 A.M. (EST) Zack Struver03 weeks 5 days ago
Blog entrySCP24: KEI statement on exceptions and limitations to patent rights thiru03 weeks 6 days ago
Blog entryStanding Committee on the Law of Patents (SCP) - GRULAC proposal - Revision of 1979 WIPO Model Law for Developing Countries thiru03 weeks 6 days ago
Blog entryColombia Issues Public Interest Declaration To Lower Price of Glivec KEI Staff04 weeks 4 days ago
Blog entryHuman Rights Council heats up during informal talks on the primacy of human rights over international trade and IP regimes thiru04 weeks 4 days ago
Blog entryS. Ward Casscells, Pentagon Medical Chief, Praised Army Role in Xtandi Development Zack Struver04 weeks 5 days ago